Shattuck Labs · 15 hours ago
Director (Sr. Director), Clinical Operations
Shattuck Labs is a company focused on building transformative medicines for patients suffering from life-altering diseases. The Director of Clinical Operations will lead and oversee the planning, execution, and management of clinical trials, ensuring compliance with regulatory standards and driving operational excellence across multiple clinical programs.
BiopharmaBiotechnologyLife Science
Responsibilities
Lead the design, implementation, and management of clinical trial operations from study start-up through close-out
Provide primary oversight for the CRO, ensuring that CRO activities are executed per study timelines. Maintain frequent and meaningful contact with the CRO to assess performance and provide oversight and guidance as needed
Collaborate with cross-functional departments such as Regulatory Affairs, Data Management, and Clinical Development, to ensure alignment and compliance
Ensure adherence to all regulatory requirements, company policies, and industry standards including FDA regulations and ICH-GCP guidelines
Identify and mitigate operational risks, implementing corrective actions as necessary to maintain study integrity and patient safety
Drive process improvements and implement best practices to enhance clinical trial efficiency and data quality
Contribute to review of other study documents such as protocols/amendments, eCRFs, clinical study reports, IBs, DSURs, conference presentations, publications, etc
In coordination with the cross-functional team, participate in the RFP process and ultimately select CROs, and other vendors for clinical trials
Participate in the selection of investigational sites with input from relevant stakeholders. Lead the study and site feasibility process in association with the CRO. Assess site and investigator performance and enrollment on a regular basis
Develop and oversee clinical operations budgets, timelines, and resource plans to ensure project milestones are met
Work closely with Clinical team members to ensure investigational product needs for clinical studies are available and managed appropriately
Partner closely with internal functional areas to operationalize the procurement and analysis of biological samples for the study, including contributing to lab manuals, identifying vendors for lab kitting and sample management, and providing regular training and feedback to sites regarding completeness and quality of sample collection
Oversee the creation and maintenance of all trial files, including the trial master file. Work with quality assurance to ensure inspection readiness of sites and implement risk-based quality management of the clinical study
Mentor clinical operations team members to promote professional growth and high performance
Qualification
Required
Bachelor's or Masters degree in science or healthcare with a minimum of 10+ years of Clinical Operations experience, including at least 8 years in direct management of clinical trials
Knowledge of clinical drug development, with experience in Phases I-III, CRO/vendor oversight, global clinical trials, and budget/timeline management
Thorough understanding of ICH GCP and FDA guidelines
Strong interpersonal skills with demonstrated ability to effectively work with internal cross-functional as well as external groups
Good communication and interpersonal skills and ability to work with cross-functional teams
Self-starter with an entrepreneurial spirit and a good team player
Strong computer skills with demonstrated experience in working with the MS Office platform
Benefits
Competitive salary and health benefits, 401k.
Opportunities for training and career advancement.
Collaborative and inclusive work environment.
Access to cutting-edge research and technology.
Company
Shattuck Labs
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Funding
Current Stage
Public CompanyTotal Funding
$328.02MKey Investors
OrbiMedRedmile Group
2025-08-05Post Ipo Equity· $103M
2023-12-21Post Ipo Equity· $50M
2020-10-08IPO
Leadership Team
Recent News
The Motley Fool
2026-01-06
2025-12-16
Company data provided by crunchbase